Tag: etrasimod
Pfizer: promising results for etrasimod
(CercleFinance.com) – Pfizer today announced positive results from a Phase 3 study of etrasimod as a potential treatment for moderate to severe active ulcerative colitis (UC). In this 52-week study,…
Pfizer: Positive results of a trial around etrasimod
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Pfizer: positive results of a trial around etrasimod
(CercleFinance.com) – Pfizer today presents the first positive results of a phase 3 study on etrasimod as a treatment for severe active ulcerative colitis (UC). In the study, patients treated…